• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Wall Street Looks Set For Modestly Lower Start Ahead Of Key Data, Tech Stocks Muted In Premarket: Analyst Says 'Bearish Sentiment Has Become Understandably Quiet'

    6/21/24 7:25:56 AM ET
    $DJT
    $FDS
    $KMX
    $NVDA
    Computer Software: Programming Data Processing
    Technology
    Computer Software: Programming, Data Processing
    Technology
    Get the next $DJT alert in real time by email

    Wall Street is on track for a lackluster open after the S&P 500’s back-to-back record performances in the first two sessions of the week. The major index futures were all uniformly lower in early trading. Given the wall of worry over growth, traders are expected to closely watch data on private sector activity, existing home sales, and a composite leading index. If the tech stocks fight back and push higher, in all likelihood, the market may finish a strong week firmer.

    “The momentum remains positive, with the VIX up modestly but still below 13, as bearish sentiment has become understandably quiet given one new high after another,” said fund manager Louis Navellier in a note to his clients.

    FuturesPerformance (+/-)
    Nasdaq 100-0.12%
    S&P 500-0.14%
    Dow-0.13%
    R2K+0.02%
    In premarket trading on Friday, the SPDR S&P 500 ETF Trust (NYSE:SPY) fell 0.11% at $544.65, while the Invesco QQQ ETF (NASDAQ:QQQ) traded down 0.09% at $481.03, according to Benzinga Pro data.

    Cues From Last Session:

    IT stocks served as drags on Thursday, offsetting strength in energy, consumer discretionary, communication services, financial, and utility stocks. The major averages started the session on a mixed note but turned uniformly higher in early trading amid the release of weak economic data that raised hopes for rate cuts this year. Jobless claims for the recent reporting week fell, albeit by less than expected, housing starts trailed expectations and a regional manufacturing survey showed smaller-than-expected expansion in activity.

    Growth worries smothered rate optimism and the averages reversed course and moved steadily lower, bottoming by late-afternoon trading. Although they rebounded from the lows, the S&P 500 Index and the Nasdaq Composite ended in the red. The 30-stock Dow Jones Industrial Average hovered mostly above the unchanged line before ending firmly in positive territory.

    Index Performance (+/-)Value
    Nasdaq Composite-0.79%17,721.59
    S&P 500 Index-0.25%5,473.17
    Dow Industrials+0.77%39,134.76
    Russell 2000-0.39%2,017.39

    Insights From Analysts:

    The market could be facing downside risk stemming from the return of volatility, said LPL Chief Technical Strategist Adam Turnquist. The equity market is currently enjoying a backdrop of extremely low volatility, thanks to decelerating inflation, the prospect of less restrictive monetary policy, enthusiasm over artificial intelligence, and resilient corporate earnings and economic growth, he said.

    Period of low implied volatility is historically associated with above-average equity market returns, Turnquist said. That said, he cautioned about a potential rise in volatility. “Seasonal VIX trends and rising expectations for increased volatility of volatility suggest the days may be numbered for the current low-volatility backdrop,” he said.

    Morgan Stanley Chief Investment Officer Lisa Shalett said in a recent note to clients that if a soft-landing scenario materializes, the equity market gains could broaden. Currently, the market is rallying on enthusiasm around AI, with a handful of large tech stocks driving the advance, she said. If the rally broadens out, the analyst said investors would likely benefit from equal-weighted stock-index strategies and active stock-picking across sectors. 

    Upcoming Economic Data:

    • S&P Global will release the results of its preliminary manufacturing and services sectors surveys at 9:45 a.m. EDT. The flash manufacturing purchasing managers’ index may have edged down from 51.3 in May to 54 in June, and the service sector PMI may have slipped from 54.8 to 54.
    • The National Association of Realtors is scheduled to release its existing home sales report for May at 10 a.m. EDT. Economists, on average, expect existing home sales to come in at a seasonally adjusted annual rate of 4.08 million units, down from 4.14 million units.
    • The Conference Board’s leading economic index for May, due at 10 a.m. EDT, may show a decline of 0.3% month-over-month, a slower rate of drop than April’s 0.6% fall.

    See Also: How To Trade Futures

    Stocks In Focus:

    • Smith & Wesson Brands, Inc. (NASDAQ:SWBI) fell over 8.5% in premarket trading following the company’s earnings announcement.
    • CarMax, Inc. (NYSE:KMX) and FactSet Research Systems Inc. (NYSE:FDS) are due to release their quarterly results before the market opens.
    • Sarepta Therapeutics, Inc. (NASDAQ:SRPT) climbed about 38% after the FDA approved an expanded label for its Duchenne muscular dystrophy treatment.
    • Trump Media & Technology Group Corp. (NASDAQ:DJT) rebounded by over 1% following its recent slide.
    • Nvidia Corp. (NASDAQ:NVDA) may extend its slide as it traded down by about 1.50% in the premarket.

    Commodities, Bonds And Global Equity Markets:

    Crude oil futures were little changed above the $81-a-barrel mark and gold futures extended their gain, with the yellow metal trading above $2,375. The 10-year benchmark U.S. treasury yield edged down 2.8 basis points to 4.226%.

    Bitcoin (CRYPTO: BTC) retreated below the $64,000 mark.

    Most major Asian markets retreated, with the Hong Kong, New Zealand, and South Korean markets leading the declines. Traders in the region reacted to the lackluster performance of Wall Street overnight and some disappointing domestic data. The Australian, Indonesian, and Singaporean markets, however, bucked the downtrend.

    European stocks traded sharply lower in early trading as the eurozone private activity data trailed expectations.

    Read Next: World’s Biggest S&P 500 ETF Bleeds Outflows: Why Isn’t The Market Crashing?

    Image Via Shutterstock

    Get the next $DJT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DJT
    $FDS
    $KMX
    $NVDA

    CompanyDatePrice TargetRatingAnalyst
    FactSet Research Systems Inc.
    $FDS
    2/17/2026$195.00Underperform
    BofA Securities
    Sarepta Therapeutics Inc.
    $SRPT
    1/28/2026$20.00Equal Weight
    Barclays
    NVIDIA Corporation
    $NVDA
    1/15/2026$240.00Outperform
    RBC Capital Mkts
    FactSet Research Systems Inc.
    $FDS
    12/17/2025$307.00Underweight → Equal-Weight
    Morgan Stanley
    Sarepta Therapeutics Inc.
    $SRPT
    12/9/2025$32.00Outperform
    Wedbush
    NVIDIA Corporation
    $NVDA
    11/21/2025$272.00Strong Buy
    Raymond James
    NVIDIA Corporation
    $NVDA
    11/20/2025$225.00 → $275.00Outperform
    Robert W. Baird
    NVIDIA Corporation
    $NVDA
    11/20/2025$240.00 → $250.00Buy
    Jefferies
    More analyst ratings

    $DJT
    $FDS
    $KMX
    $NVDA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    MD,Controller and CAO Moskoff Gregory T was granted 22 shares and covered exercise/tax liability with 9 shares, increasing direct ownership by 8% to 183 units (SEC Form 4)

    4 - FACTSET RESEARCH SYSTEMS INC (0001013237) (Issuer)

    2/17/26 4:07:44 PM ET
    $FDS
    Computer Software: Programming, Data Processing
    Technology

    EVP & Chief Financial Officer Kress Colette sold $8,371,233 worth of Common (47,640 units at $175.72), decreasing direct ownership by 3% to 846,772 units (SEC Form 4)

    4 - NVIDIA CORP (0001045810) (Issuer)

    2/6/26 5:06:41 PM ET
    $NVDA
    Semiconductors
    Technology

    Director Nicaise Claude exercised 10,500 shares at a strike of $13.71 and covered exercise/tax liability with 6,780 shares, increasing direct ownership by 13% to 31,532 units (SEC Form 4)

    4 - Sarepta Therapeutics, Inc. (0000873303) (Issuer)

    1/29/26 8:05:03 PM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DJT
    $FDS
    $KMX
    $NVDA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BofA Securities resumed coverage on FactSet with a new price target

    BofA Securities resumed coverage of FactSet with a rating of Underperform and set a new price target of $195.00

    2/17/26 7:37:46 AM ET
    $FDS
    Computer Software: Programming, Data Processing
    Technology

    Barclays resumed coverage on Sarepta Therapeutics with a new price target

    Barclays resumed coverage of Sarepta Therapeutics with a rating of Equal Weight and set a new price target of $20.00

    1/28/26 7:19:11 AM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    RBC Capital Mkts initiated coverage on NVIDIA with a new price target

    RBC Capital Mkts initiated coverage of NVIDIA with a rating of Outperform and set a new price target of $240.00

    1/15/26 8:38:56 AM ET
    $NVDA
    Semiconductors
    Technology

    $DJT
    $FDS
    $KMX
    $NVDA
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for AMONDYS 45 issued to SAREPTA THERAPS INC

    Submission status for SAREPTA THERAPS INC's drug AMONDYS 45 (SUPPL-8) with active ingredient CASIMERSEN has changed to 'Approval' on 07/11/2024. Application Category: NDA, Application Number: 213026, Application Classification: Labeling

    7/12/24 4:40:36 AM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    June 20, 2024 - FDA Expands Approval of Gene Therapy for Patients with Duchenne Muscular Dystrophy

    For Immediate Release: June 20, 2024 Today, the U.S. Food and Drug Administration expanded the approval of Elevidys (delandistrogene moxeparvovec-rokl), a gene therapy for the treatment of Duchenne muscular dystrophy (DMD) for ambulatory and non-ambulatory individuals 4 years of age and older with DMD with a confirmed mutation in the DMD gene.  Elevidys was previously approved under accelerated approval for amb

    6/20/24 5:24:42 PM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for VYONDYS 53 issued to SAREPTA THERAPS INC

    Submission status for SAREPTA THERAPS INC's drug VYONDYS 53 (SUPPL-11) with active ingredient GOLODIRSEN has changed to 'Approval' on 06/04/2024. Application Category: NDA, Application Number: 211970, Application Classification: Labeling

    6/5/24 4:41:31 AM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DJT
    $FDS
    $KMX
    $NVDA
    SEC Filings

    View All

    SEC Form 13F-HR filed by NVIDIA Corporation

    13F-HR - NVIDIA CORP (0001045810) (Filer)

    2/17/26 4:27:55 PM ET
    $NVDA
    Semiconductors
    Technology

    SEC Form SCHEDULE 13G filed by CarMax Inc

    SCHEDULE 13G - CARMAX INC (0001170010) (Subject)

    2/13/26 11:17:04 AM ET
    $KMX
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    SEC Form 13F-HR filed by Sarepta Therapeutics Inc.

    13F-HR - Sarepta Therapeutics, Inc. (0000873303) (Filer)

    2/12/26 8:57:42 PM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DJT
    $FDS
    $KMX
    $NVDA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Yorkville America Equities, LLC and Truth Social Funds Announce Proposed Acquisition of the Point Bridge America First ETF (MAGA)

    SARASOTA, Fla., Feb. 19, 2026 /PRNewswire/ -- Yorkville America Equities, LLC ("Yorkville"), investment adviser for the Truth Social Funds, today announced that it has entered into an agreement to acquire the Point Bridge America First ETF (Ticker: MAGA) into the Truth Social Funds product suite. The respective Board of Trustees of the Truth Social Funds and ETF Series Solutions have approved this transaction, which, if approved by shareholders, is expected to close in Q2 2026. The Truth Social Funds and each of its existing ETF series are part of the Truth.Fi fintech brand from Trump Media & Technology Group Corp. (Nasdaq, NYSE Texas: DJT) ("Trump Media"), operator of the social media platf

    2/19/26 9:00:00 AM ET
    $DJT
    Computer Software: Programming Data Processing
    Technology

    Meta Builds AI Infrastructure With NVIDIA

    News Summary: Meta expands NVIDIA CPU deployment and significantly improves performance per watt in its data centers.Meta scales out AI workloads with NVIDIA Spectrum-X Ethernet, supporting network efficiency and throughput.Meta has adopted NVIDIA Confidential Computing, enabling AI capabilities while protecting user privacy. SANTA CLARA, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- NVIDIA today announced a multiyear, multigenerational strategic partnership with Meta spanning on-premises, cloud and AI infrastructure. Meta will build hyperscale data centers optimized for both training and inference in support of the company's long-term AI infrastructure roadmap. This partnership will enable

    2/17/26 4:15:00 PM ET
    $NVDA
    Semiconductors
    Technology

    Closing the Intent-to-Execution Gap May Define Next Wave of AI Investment

    AUSTIN, Texas, Feb. 17, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage: As artificial intelligence (AI) evolves beyond generative chat systems into agentic AI capable of autonomous action, a critical bottleneck has emerged: the lack of high-fidelity, real-time input connecting human intent to machine execution. While AI models can generate text, images or strategies, translating subtle human signals into actionable machine instructions remains a major technical challenge. Without precise and continuous intent capture, autonomous systems — from humanoid robotics to extended reality (XR) environments — struggle to operate seamlessly alongside humans. Wearable Devices Ltd. (NASDAQ:WLD

    2/17/26 8:30:00 AM ET
    $GOOG
    $NVDA
    $WLDS
    Computer Software: Programming Data Processing
    Technology
    Semiconductors
    Computer Communications Equipment

    $DJT
    $FDS
    $KMX
    $NVDA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    General Counsel and Secretary Glabe Scott bought $10,465 worth of shares (1,000 units at $10.46), increasing direct ownership by 0.31% to 326,236 units (SEC Form 4)

    4 - Trump Media & Technology Group Corp. (0001849635) (Issuer)

    11/19/25 8:48:25 PM ET
    $DJT
    Computer Software: Programming Data Processing
    Technology

    EVP, Chief Revenue Officer Skoko Goran bought $126,465 worth of shares (500 units at $252.93), increasing direct ownership by 6% to 9,192 units (SEC Form 4)

    4 - FACTSET RESEARCH SYSTEMS INC (0001013237) (Issuer)

    11/10/25 4:15:37 PM ET
    $FDS
    Computer Software: Programming, Data Processing
    Technology

    EVP, Chief Financial Officer Shan Helen L. bought $101,928 worth of shares (370 units at $275.48), increasing direct ownership by 4% to 9,284 units (SEC Form 4)

    4 - FACTSET RESEARCH SYSTEMS INC (0001013237) (Issuer)

    10/8/25 4:28:08 PM ET
    $FDS
    Computer Software: Programming, Data Processing
    Technology

    $DJT
    $FDS
    $KMX
    $NVDA
    Leadership Updates

    Live Leadership Updates

    View All

    CarMax Names Keith Barr as Chief Executive Officer

    CarMax, Inc. (NYSE:KMX) ("CarMax" or the "Company") today announced that Keith Barr has been appointed President and Chief Executive Officer, and a member of the Board of Directors ("the Board"), effective March 16, 2026. David McCreight, current Interim President and CEO of CarMax, will transition to his prior duties as an independent Director of the Board. Tom Folliard will remain in his role as Interim Executive Chair of the Board until the Company's Annual Meeting in June 2026, after which he is expected to resume his prior duties as non-executive Chair of the Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/2026021283385

    2/12/26 6:50:00 AM ET
    $IHG
    $KMX
    Hotels/Resorts
    Consumer Discretionary
    Retail-Auto Dealers and Gas Stations

    Barclays and FactSet enter a multiyear strategic agreement

    NORWALK, Conn., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Barclays today announced a multiyear arrangement with FactSet (NYSE:FDS, NASDAQ:FDS), a global financial digital platform and enterprise solutions provider, as a further step in realizing Barclays' long-term market data strategy. This collaboration harnesses FactSet's advanced analytics and innovative technology, empowering Barclays to deliver enhanced, data-driven solutions for its global client base. "Market data is undergoing an intense period of change whereby customers of market data providers are evolving from consumers to co-creators of capabilities to yield competitive insights," said Georges Lauchard, Investment Bank COO at Barcla

    1/22/26 8:45:00 AM ET
    $FDS
    Computer Software: Programming, Data Processing
    Technology

    Palantir and NVIDIA Team Up to Operationalize AI — Turning Enterprise Data Into Dynamic Decision Intelligence

    News Summary Palantir is integrating NVIDIA accelerated computing, NVIDIA CUDA-X libraries and open-source NVIDIA Nemotron models into its Ontology framework at the core of the Palantir AI Platform.Lowe's is pioneering operational AI for its supply chain logistics with Palantir and NVIDIA. WASHINGTON, Oct. 28, 2025 (GLOBE NEWSWIRE) -- GTC Washington, D.C. -- NVIDIA today announced a collaboration with Palantir Technologies Inc. to build a first-of-its-kind integrated technology stack for operational AI — including analytics capabilities, reference workflows, automation features and customizable, specialized AI agents — to accelerate and optimize complex enterprise and government systems.

    10/28/25 1:36:17 PM ET
    $NVDA
    Semiconductors
    Technology

    $DJT
    $FDS
    $KMX
    $NVDA
    Financials

    Live finance-specific insights

    View All

    Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2025 Financial Results

    Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report fourth quarter and full-year 2025 financial results after the Nasdaq Global Market closes on Wednesday, Feb. 25, 2026. Subsequently, at 4:30 p.m. E.T., the Company will host a conference call to discuss its fourth quarter and full-year 2025 financial results. The event will be webcast live under the investor relations section of Sarepta's website at https://investorrelations.sarepta.com/events-presentations and following the event a replay will be archived there for one year. Interested parties participating by phone will need to register using this online form. After register

    2/11/26 8:30:00 AM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FactSet Declares Dividend

    NORWALK, Conn., Feb. 05, 2026 (GLOBE NEWSWIRE) -- FactSet (NYSE:FDS, NASDAQ:FDS), a global financial digital platform and enterprise solutions provider, today announced that its Board of Directors approved a regular quarterly cash dividend of $1.10 per share. The cash dividend will be paid on March 19, 2026, to holders of record of FactSet's common stock at the close of business on February 27, 2026. About FactSetFactSet (NYSE:FDS, NASDAQ:FDS) supercharges financial intelligence, offering enterprise data and information solutions that power our clients to maximize their potential. Our cutting-edge digital platform seamlessly integrates proprietary financial data, client datasets, third-p

    2/5/26 7:00:00 AM ET
    $FDS
    Computer Software: Programming, Data Processing
    Technology

    Institutional-Grade Token Architecture Positions Companies at the Center of Digital Finance

    Scalable, compliant infrastructure supports demand for regulated digital assets for growing number of industries  Market News Updates News Commentary NEW YORK, Feb. 4, 2026 /PRNewswire/ -- Digital finance is moving fast, and institutional-grade token architecture is becoming a core piece of the financial system. Large investors and institutions want digital assets that are secure, compliant, and easy to integrate with traditional finance. Tokenized infrastructure built for institutions helps make that possible by supporting regulated transactions, asset-backed tokens, and scalable platforms designed for real-world use, not just experimentation as Active Companies take notice that may include

    2/4/26 8:45:00 AM ET
    $COIN
    $DJT
    $GNLN
    Finance: Consumer Services
    Finance
    Computer Software: Programming Data Processing
    Technology

    $DJT
    $FDS
    $KMX
    $NVDA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Trump Media & Technology Group Corp.

    SC 13G/A - Trump Media & Technology Group Corp. (0001849635) (Subject)

    11/14/24 9:53:48 PM ET
    $DJT
    Computer Software: Programming Data Processing
    Technology

    Amendment: SEC Form SC 13G/A filed by Sarepta Therapeutics Inc.

    SC 13G/A - Sarepta Therapeutics, Inc. (0000873303) (Subject)

    11/13/24 10:27:59 AM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by NVIDIA Corporation

    SC 13G/A - NVIDIA CORP (0001045810) (Subject)

    11/12/24 10:32:12 AM ET
    $NVDA
    Semiconductors
    Technology